Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Anthony Fenton"'
Autor:
Katherine Phillips, Jonathan M. Hazlehurst, Christelle Sheppard, Srikanth Bellary, Wasim Hanif, Muhammad Ali Karamat, Francesca L. Crowe, Anna Stone, G. Neil Thomas, Javeria Peracha, Anthony Fenton, Christopher Sainsbury, Krishnarajah Nirantharakumar, Indranil Dasgupta
Publikováno v:
Diabetic Medicine.
Autor:
Derek Kyte, Krishnarajah Nirantharakumar, Paul Cockwell, Krishna Gokhale, Nicola J Adderley, Harjeet Kaur Bhachu, Anthony Fenton, Anuradhaa Subramanian, Melanie Calvert
Publikováno v:
Kidney International Reports
Introduction The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of end-stage renal disease (ESRD) has been developed, but its potential impact in a population on referrals for patients with chronic kidney disease (CKD) f
Autor:
Helen R. Griffiths, Mutahir Rahman, Amneet Sidhu, Brenda Heaton, Charles J. Ferro, Caroline L. R. Brown, Praveen Sharma, Paul Cockwell, Irundika H.K. Dias, Anthony Fenton, Thomas Dietrich, Iain L. C. Chapple
Publikováno v:
Journal of Clinical Periodontology
Aims Patients with chronic kidney disease (CKD) are also susceptible to periodontitis. The causal link between periodontitis and CKD may be mediated via systemic inflammation/oxidative stress. Using structural equation modelling (SEM), this cross‐s
Autor:
Harjeet Kaur Bhachu, Anthony Fenton, Paul Cockwell, Olalekan Aiyegbusi, Derek Kyte, Melanie Calvert
Publikováno v:
Online: 2044-6055 Print: ISSN 2044-6055
BMJ Open
BMJ Open, Vol 12, Iss 1 (2022)
BMJ Open
BMJ Open, Vol 12, Iss 1 (2022)
Rationale and objectiveThe Kidney Failure Risk Equation (KFRE) predicts the risk of end-stage kidney disease in patients with chronic kidney disease (CKD). This study aimed to evaluate the impact of the utility of KFRE in clinical practice.Study desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c01451cd76f979cac52ecaf81457d6f5
Autor:
Siang Ing Lee, Jennifer Cooper, Anthony Fenton, Anuradhaa Subramanian, Tom Taverner, Krishna M. Gokhale, Katherine Phillips, Mitesh Patel, Lorraine Harper, G. Neil Thomas, Krishnarajah Nirantharakumar
Publikováno v:
Alzheimer'sdementia : the journal of the Alzheimer's AssociationREFERENCES. 18(10)
Decreased renal function is a potential risk factor for dementia.This retrospective cohort study of 2.8 million adults aged ≥50 years used the IMRD-THIN database, representative of UK primary care, from January 1, 1995 to February 24, 2020. The ass
Autor:
Charles J. Ferro, Alvin H. K. Karangizi, Anthony Fenton, Dimitrios Chanouzas, Paul Moss, Paul Cockwell, Lorraine Harper
Publikováno v:
QJM : monthly journal of the Association of Physicians. 113(9)
BACKGROUND Cardiovascular disease (CVD) is the leading cause of early death in patients with chronic kidney disease (CKD). Previous work has described an association between Cytomegalovirus (CMV) seropositivity and CVD amongst patients with dialysis
Autor:
Rajkumar Chinnadurai, Latha Gullapudi, Anthony Fenton, Charles J. Ferro, James Ritchie, Indranil Dasgupta, Maarten W. Taal, Paul Cockwell, Petros Kampanis, Stephen Harding, Philip A. Kalra
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 2, p e1003050 (2020)
PLoS Medicine, Vol 17, Iss 2, p e1003050 (2020)
Background In studies including the general population, the presence of non-malignant monoclonal gammopathy (MG) can be causally associated with kidney damage and shorter survival. We assessed whether the presence of an MG is associated with a higher
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
BMC Nephrology
BMC Nephrology
Background Minimal change disease (MCD) is a common cause of the nephrotic syndrome in adults with limited evidence on its treatment and prognosis. We examined the presenting characteristics, treatments, and outcomes of adult patients with MCD in our
Autor:
Mark Jesky, Federica Genovese, Daniel Guldager Kring Rasmussen, Anthony Fenton, Charles J. Ferro, Morten A. Karsdal, Paul Cockwell
Publikováno v:
Clinical Kidney Journal
Background Tubulointerstitial fibrosis is a major pathological feature in chronic kidney disease (CKD) and collagen type III (COL3) is a major component of the renal fibrotic scar. We hypothesized that a dysregulated turnover of COL3 is an important
Autor:
Paula F. Orlandi, Jing Huang, Masafumi Fukagawa, Wendy Hoy, Vivekanand Jha, Kook-Hwan Oh, Laura Sola, Paul Cockwell, Adeera Levin, Harold I. Feldman, Wendy E. Hoy, Zaimin Wang, Jianzhen Zhang, Helen G. Healy, Anthony Fenton, Lisa Nessel, Alan Go, Lawrence Appel, Curie Ahn, Dong Wan Chae, Seung Hyeok Han, Ognjenka Djurdjev, Mila Tang, Pablo G. Rios, Liliana Gadola, Takayuki Hamano, Naohiko Fujii, Takahiro Imaizumi, Ashok Kumar Yadav, Vivek Kumar
Rates of chronic kidney disease (CKD) progression, end stage kidney disease (ESKD), all-cause mortality, and cardiovascular (CVD) events among individuals with CKD vary widely across countries. Well-characterized demographic, comorbidity, and laborat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bb14bbb337df8962d975cca13acce9
https://ora.ox.ac.uk/objects/uuid:35be067f-c0d8-45f6-bde8-ec3f3573d973
https://ora.ox.ac.uk/objects/uuid:35be067f-c0d8-45f6-bde8-ec3f3573d973